OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovations in ...

Investing.com -- OSR Holdings Inc (NASDAQ:OSRH) stock surged 30.5% on Friday after the company announced its subsidiary Vaximm AG had entered a non-binding term sheet with BCM Europe AG to explore a ...

OSR Holdings (OSRH) announced that Vaximm AG, an OSR company, has entered into a non-binding term sheet with BCM Europe AG, a Swiss-based life ...

Summary • OSR Holdings, Inc. (OSRH) stock has surged 52.35% to $0.6947, with over 49 million shares traded today.• The rise ...

As pharmaceutical giants increasingly look outside their walls for breakthrough innovations, the licensing model has become ...

In this episode, Bertrand Tombal discusses the latest updates in genitourinary cancers presented at ESMO 2025.

The FDA will now allow biotechs to ask agency staff for “quick clarifications” via email. Elsewhere, Novartis hiked guidance for two top drugs and a startup nearing “unicorn” status secured a ...

According to DataM Intelligence, the Prostate Cancer Drugs Market Size reached USD 13.22 billion in 2024 and is projected to ...

The European Investment Bank has signed a €50 million loan agreement with finance&invest.brussels to support business growth and job creation in the Brussels Capital Region. The funding will enable ...